Intercept Pharmaceuticals, Inc. (ICPT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 01:00PM EST
After hours:
| Previous close | 14.81 |
| Open | 14.65 |
| Bid | 14.73 x 1000 |
| Ask | 14.76 x 800 |
| Day's range | 14.55 - 14.99 |
| 52-week range | 10.81 - 21.25 |
| Volume | |
| Avg. volume | 874,301 |
| Market cap | 611.731M |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Intercept Pharmaceuticals Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
Intercept Pharmaceuticals ( NASDAQ:ICPT ) Third Quarter 2022 Results Key Financial Results Revenue: US$77.6m (up 16...
- Zacks
Intercept (ICPT) Q3 Earnings Miss, Sales Beat, View Raised
Intercept (ICPT) posts a wider loss in Q3 due to a loss on extinguishment of debt but beats on sales. Management increases annual sales guidance.
- Motley Fool
Why Intercept Pharmaceuticals Stock Is Soaring Today
Shares of Intercept Pharmaceuticals (NASDAQ: ICPT) were soaring 15.7% higher as of 12:02 p.m. ET on Tuesday. It also easily topped the average analysts' earnings estimate of $4.61 per share. Intercept's solid revenue growth was entirely due to higher Ocaliva sales.
© 2022 Yahoo. All rights reserved.
